← Back to headlines
Gilead Sciences Expects Loss Due to Acquired R&D Expenses
Gilead Sciences anticipates reporting a loss this year, primarily driven by significant expenses related to acquired research and development.
17 May, 21:37 — 17 May, 21:37
Sources
Showing 1 of 1 sources
Related Stories
Heirs Life Assurance Appoints Pastor Jerry Eze as Independent Non-Executive Director
2h ago
Nigerian Finance Minister Queries NAICOM Over Insurance Recapitalisation Fees
2h ago
Understanding Eligibility for Medicare Supplemental Insurance
4h ago
FM Sitharaman Assures No UPI Charges for Consumers as Parliament Clears Tax Bill
4h ago